The Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities

被引：133

作者：

Raskova, Magdalena ^{[1
,2
]}

Lacina, Lukas ^{[3
,4
,5
,6
]}

Kejik, Zdenek ^{[3
,4
,7
]}

Venhauerova, Anna ^{[2
]}

Skalickova, Marketa ^{[2
]}

Kolai, Michal ^{[3
,8
]}

Jakubek, Milan ^{[3
,4
,7
]}

Rosel, Daniel ^{[1
,2
]}

Smetana, Karel Jr Jr ^{[3
,4
,6
]}

Brabek, Jan ^{[1
,2
]}

机构：

[1] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague 12000, Czech Republic

[2] Charles Univ Prague, Fac Sci, BIOCEV, Vestec 25250, Czech Republic

[3] Charles Univ Prague, Fac Med 1, Ctr Tumour Ecol, Prague 12000, Czech Republic

[4] Charles Univ Prague, Fac Med 1, BIOCEV, Vestec 25250, Czech Republic

[5] Charles Univ Prague, Fac Med 1, Inst Anat, Prague 12000, Czech Republic

[6] Charles Univ Prague, Fac Med 1, Dept Dermatovenereol, Prague 12000, Czech Republic

[7] Gen Univ Hosp, Prague 12000, Czech Republic

[8] Czech Acad Sci, Inst Mol Genet, Lab Genom & Bioinformat, Prague 14000, Czech Republic

来源：

CELLS | 2022年 / 11卷 / 22期

关键词：

IL-6; cancer; metastasis; STAT3; INHIBITOR; PHASE-I; NONPEPTIDE ANTAGONIST; MITOCHONDRIAL STAT3; SIGNALING PATHWAY; TRANSCRIPTION; MADINDOLINE-A; INTERLEUKIN-6; INVASION; GROWTH;

D O I：

10.3390/cells11223698

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various homeostatic and pathological processes. These activities range from regulating embryonic development, wound healing and ageing, inflammation, and immunity, including COVID-19. In this review, we summarise the role of IL-6 signalling pathways in cancer biology, with particular emphasis on cancer cell invasiveness and metastasis formation. Targeting principal components of IL-6 signalling (e.g., IL-6Rs, gp130, STAT3, NF-kappa B) is an intensively studied approach in preclinical cancer research. It is of significant translational potential; numerous studies strongly imply the remarkable potential of IL-6 signalling inhibitors, especially in metastasis suppression.

引用

页数：23

共 160 条

[1] Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6 [J].

Abulaiti, Abulimiti ;

Shintani, Yasushi ;

Funaki, Soichiro ;

Nakagiri, Tomoyuki ;

Inoue, Masayohi ;

Sawabata, Noriyoshi ;

Minami, Masato ;

Okumura, Meinoshin .

LUNG CANCER, 2013, 82 (02) :204-213

[2] Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma [J].

Adachi, Makoto ;

Cui, Caixia ;

Dodge, Cristina T. ;

Bhayani, Mihir K. ;

Lai, Stephen Y. .

ORAL ONCOLOGY, 2012, 48 (12) :1220-1226

[3] STAT3 isoforms: Alternative fates in cancer? [J].

Aigner, Petra ;

Just, Valentin ;

Stoiber, Dagmar .

CYTOKINE, 2019, 118 :27-34

[4] Possible Role for Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia [J].

Ando, Katsutoshi ;

Takahashi, Fumiyuki ;

Motojima, Shinji ;

Nakashima, Kei ;

Kaneko, Norihiro ;

Hoshi, Kazuei ;

Takahashi, Kazuhisa .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) :E69-E72

[5]

[Anonymous], 2017, KEVZARA SARILUMAB

[6] Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors [J].

Bendell, Johanna C. ;

Hong, David S. ;

Burris, Howard A., III ;

Naing, Aung ;

Jones, Suzanne F. ;

Falchook, Gerald ;

Bricmont, Patricia ;

Elekes, Agnes ;

Rock, Edwin P. ;

Kurzrock, Razelle .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) :125-130

[7] Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection [J].

Biggioggero, Martina ;

Crotti, Chiara ;

Becciolini, Andrea ;

Favalli, Ennio Giulio .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 :57-70

[8] IL-6 trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function [J].

Boettcher, Jan P. ;

Schanz, Oliver ;

Garbers, Christoph ;

Zaremba, Anne ;

Hegenbarth, Silke ;

Kurts, Christian ;

Beyer, Marc ;

Schultze, Joachim L. ;

Kastenmueller, Wolfgang ;

Rose-John, Stefan ;

Knolle, Percy A. .

CELL REPORTS, 2014, 8 (05) :1318-1327

[9] A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas [J].

Boonstra, Philip S. ;

Polk, Avery ;

Brown, Noah ;

Hristov, Alexandra C. ;

Bailey, Nathanael G. ;

Kaminski, Mark S. ;

Phillips, Tycel ;

Devata, Sumana ;

Mayer, Tera ;

Wilcox, Ryan A. .

AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (12) :1287-1294

[10] Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer [J].

Boukalova, Stepana ;

Hubackova, Sona ;

Milosevic, Mirko ;

Ezrova, Zuzana ;

Neuzil, Jiri ;

Rohlena, Jakub .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (06)

← 1 2 3 4 5 6 7 8 9 10 →